SimCorp names Peter Sanderson as Chief Executive Officer

Sanderson has proven track record of driving growth and deep industry knowledge  Sanderson has held key leadership roles at GAM Investments, BlackRock Investment Management COPENHAGEN, Denmark, LONDON and NEW YORK, Aug. 4, 2025 /PRNewswire/ – SimCorp, a global leader in financial technology and a subsidiary of Deutsche Börse AG, today announced that Peter Sanderson will… Continue reading SimCorp names Peter Sanderson as Chief Executive Officer

SimCorp nombra a Peter Sanderson como consejero delegado

Sanderson cuenta con una trayectoria demostrada impulsando el crecimiento y un profundo conocimiento del sector. Sanderson ha ocupado puestos de liderazgo clave en GAM Investments y BlackRock Investment Management. COPENHAGUE, Dinamarca y LONDRES y NUEVA YORK, 4 de agosto de 2025 /PRNewswire/ — SimCorp, líder mundial en tecnología financiera y filial de Deutsche Börse AG,… Continue reading SimCorp nombra a Peter Sanderson como consejero delegado

SimCorp names Peter Sanderson as Chief Executive Officer

Sanderson has proven track record of driving growth and deep industry knowledge  Sanderson has held key leadership roles at GAM Investments, BlackRock Investment Management COPENHAGEN, Denmark and LONDON and NEW YORK, Aug. 4, 2025 /PRNewswire/ — SimCorp, a global leader in financial technology and a subsidiary of Deutsche Börse AG, today announced that Peter Sanderson… Continue reading SimCorp names Peter Sanderson as Chief Executive Officer

Beatbot and Jackery Partner to Bring Solar Power to Poolside Living Across Europe

Clean Energy Meets Clean Pools with Exclusive Summer Discounts BERLIN, Aug. 4, 2025 /PRNewswire/ — Beatbot, a global leader in cutting-edge robotic pool cleaning technology, is proud to announce a new partnership with Jackery, the global leader in portable power and solar energy solutions. Together, the two companies are introducing a smarter, cleaner way to enjoy… Continue reading Beatbot and Jackery Partner to Bring Solar Power to Poolside Living Across Europe

Repurchase of Truecaller B shares in week 31, 2025

STOCKHOLM, Aug. 4, 2025 /PRNewswire/ — During 28 July 2025 and 1 August 2025 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 175,000 own B shares (ISIN: SE0016787071), corresponding to 0.05% of outstanding capital, as part of the share buyback programme initiated by the board of directors. Since the start of the program… Continue reading Repurchase of Truecaller B shares in week 31, 2025

HKBU leads the development of multifunctional nanorobots for precise and effective pollutant degradation and bacterial removal

HONG KONG, Aug. 4, 2025 /PRNewswire/ — A collaborative research team led by Hong Kong Baptist University (HKBU) has developed a multifunctional nanorobot equipped with silver and gold nanorods to facilitate high-performance pollutant degradation and bacteria elimination, with its mobility navigated by the application of magnetic fields. The invention holds potential for broad applications in… Continue reading HKBU leads the development of multifunctional nanorobots for precise and effective pollutant degradation and bacterial removal

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India, Aug. 4, 2025 /PRNewswire/ — Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic… Continue reading Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Viewpoint with Dennis Quaid and DeKalb Convention & Visitors Bureau Present: Your Passport to a World of Culture

LOS ANGELES, Aug. 4, 2025 /PRNewswire/ — Viewers can prepare to have their perceptions broadened in an upcoming segment of “Viewpoint with Dennis Quaid,” partnering with the DeKalb Convention & Visitors Bureau. This captivating journey is set to uncover DeKalb County as a remarkable hub where diverse cultures converge, creating a vibrant tapestry of global… Continue reading Viewpoint with Dennis Quaid and DeKalb Convention & Visitors Bureau Present: Your Passport to a World of Culture

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

TAIPEI, Aug. 4, 2025 /PRNewswire/ — Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ABT-301, enabling the initiation of a Phase 1/2 clinical trial in combination with tislelizumab and bevacizumab for patients with metastatic colorectal cancer (mCRC). This open-label, multi-center international study… Continue reading Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

BEIJING, Aug. 3, 2025 /PRNewswire/ — Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing in its clinical trial of RTP-008 during Q2 2025. RTP-008 is a bioabsorbable tacrolimus lacrimal canaliculus plug for the treatment of dry eye disease (DED). The milestone was achieved at… Continue reading Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease